Mariner LLC Buys 4,327 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mariner LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 89,122 shares of the medical equipment provider's stock after buying an additional 4,327 shares during the quarter. Mariner LLC's holdings in Intuitive Surgical were worth $46,520,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of ISRG. Norges Bank bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $2,401,493,000. Proficio Capital Partners LLC increased its holdings in shares of Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock valued at $495,845,000 after purchasing an additional 948,902 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Intuitive Surgical during the 4th quarter worth about $313,769,000. Wilmington Savings Fund Society FSB grew its stake in Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock valued at $272,980,000 after buying an additional 552,058 shares during the last quarter. Finally, Vanguard Group Inc. grew its position in shares of Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after purchasing an additional 360,591 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 in the last ninety days. 0.70% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. Piper Sandler restated an "overweight" rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Bernstein Bank lifted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. Citigroup increased their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. Finally, Robert W. Baird dropped their price objective on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating for the company in a report on Tuesday, March 18th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $611.81.

Intuitive Surgical Trading Down 3.0 %

NASDAQ:ISRG traded down $14.41 on Monday, reaching $468.33. 620,152 shares of the stock traded hands, compared to its average volume of 1,585,844. The company's 50 day moving average is $522.23 and its 200-day moving average is $532.71. Intuitive Surgical, Inc. has a 1-year low of $364.31 and a 1-year high of $616.00. The firm has a market capitalization of $166.81 billion, a price-to-earnings ratio of 73.06, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.